Press coverage about Global Medical REIT (NYSE:GMRE) has been trending somewhat positive recently, according to Accern. The research group ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Global Medical REIT earned a news impact score of 0.04 on Accern’s scale. Accern also gave media stories about the company an impact score of 46.2507371275169 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Global Medical REIT (NYSE:GMRE) opened at $8.00 on Tuesday. Global Medical REIT has a 1-year low of $7.72 and a 1-year high of $10.25. The firm has a market cap of $173.48, a P/E ratio of 20.56, a P/E/G ratio of 1.27 and a beta of -0.04. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.22 and a quick ratio of 0.22.

How to Become a New Pot Stock Millionaire

Global Medical REIT (NYSE:GMRE) last announced its quarterly earnings data on Thursday, November 9th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.10). Global Medical REIT had a negative return on equity of 2.86% and a negative net margin of 19.98%. analysts anticipate that Global Medical REIT will post 0.34 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 10th. Investors of record on Tuesday, December 26th were issued a $0.20 dividend. The ex-dividend date of this dividend was Friday, December 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 10.00%. Global Medical REIT’s payout ratio is currently -296.30%.

GMRE has been the subject of several recent research reports. B. Riley reiterated a “buy” rating on shares of Global Medical REIT in a report on Wednesday, November 1st. Zacks Investment Research lowered shares of Global Medical REIT from a “hold” rating to a “sell” rating in a report on Tuesday, November 7th. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $10.45.

ILLEGAL ACTIVITY WARNING: “Global Medical REIT (GMRE) Receives Daily Media Sentiment Rating of 0.04” was published by Marea Informative and is owned by of Marea Informative. If you are viewing this piece on another website, it was copied illegally and republished in violation of United States and international trademark & copyright law. The original version of this piece can be accessed at https://www.mareainformativa.com/2018/01/30/global-medical-reit-gmre-getting-somewhat-favorable-press-coverage-report-finds-updated-updated-updated.html.

About Global Medical REIT

Global Medical REIT Inc is engaged primarily in the acquisition of licensed, purpose-built healthcare facilities and the leasing of these facilities to clinical operators with market share. The Company’s strategy is to produce increasing, reliable rental revenue by expanding its portfolio, and leasing its healthcare facilities to market operators under long-term triple-net leases.

Insider Buying and Selling by Quarter for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.